158 related articles for article (PubMed ID: 17985405)
1. Initiation of disease-modifying antirheumatic drug therapy in minority and disadvantaged patients with rheumatoid arthritis.
Suarez-Almazor ME; Berrios-Rivera JP; Cox V; Janssen NM; Marcus DM; Sessoms S
J Rheumatol; 2007 Dec; 34(12):2400-7. PubMed ID: 17985405
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
Kremers HM; Nicola P; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
[TBL] [Abstract][Full Text] [Related]
3. Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis.
Hernández-García C; Vargas E; Abásolo L; Lajas C; Bellajdell B; Morado IC; Macarrón P; Pato E; Fernández-Gutiérrez B; Bañares A; Jover JA
J Rheumatol; 2000 Oct; 27(10):2323-8. PubMed ID: 11036824
[TBL] [Abstract][Full Text] [Related]
4. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
[TBL] [Abstract][Full Text] [Related]
5. Disappointing longterm results with disease modifying antirheumatic drugs. A practice based study.
Galindo-Rodriguez G; Aviña-Zubieta JA; Russell AS; Suarez-Almazor ME
J Rheumatol; 1999 Nov; 26(11):2337-43. PubMed ID: 10555887
[TBL] [Abstract][Full Text] [Related]
6. "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy.
Capell H; McCarey D; Madhok R; Hampson R
J Rheumatol; 2002 Oct; 29(10):2099-105. PubMed ID: 12375318
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database study.
Bonafede MM; Fox KM; Johnson BH; Watson C; Gandra SR
Clin Ther; 2012 Feb; 34(2):457-67. PubMed ID: 22284901
[TBL] [Abstract][Full Text] [Related]
8. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs.
Malysheva OA; Wahle M; Wagner U; Pierer M; Arnold S; Häntzschel H; Baerwald CG
J Rheumatol; 2008 Jun; 35(6):979-85. PubMed ID: 18412314
[TBL] [Abstract][Full Text] [Related]
9. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
[TBL] [Abstract][Full Text] [Related]
10. Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics.
Carli C; Ehlin AG; Klareskog L; Lindblad S; Montgomery SM
Ann Rheum Dis; 2006 Aug; 65(8):1102-5. PubMed ID: 16322085
[TBL] [Abstract][Full Text] [Related]
11. Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
Agarwal S; Zaman T; Handa R
Singapore Med J; 2009 Jul; 50(7):686-92. PubMed ID: 19644623
[TBL] [Abstract][Full Text] [Related]
12. Importance of psychological well being and disease activity in termination of an initial DMARD therapy.
Listing J; Alten R; Brauer D; Eggens U; Gromnica-Ihle E; Hagemann D; Hauer R; Milleck D; Reuter U; Schlittgen R; Sörensen H; Zink A
J Rheumatol; 1997 Nov; 24(11):2097-105. PubMed ID: 9375866
[TBL] [Abstract][Full Text] [Related]
13. Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal.
Schmajuk G; Schneeweiss S; Katz JN; Weinblatt ME; Setoguchi S; Avorn J; Levin R; Solomon DH
Arthritis Rheum; 2007 Aug; 57(6):928-34. PubMed ID: 17665462
[TBL] [Abstract][Full Text] [Related]
14. Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996.
Ward MM; Fries JF
J Rheumatol; 1998 Mar; 25(3):408-16. PubMed ID: 9517756
[TBL] [Abstract][Full Text] [Related]
15. Patient decision-making related to antirheumatic drugs in rheumatoid arthritis: the importance of patient trust of physician.
Martin RW; Head AJ; René J; Swartz TJ; Fiechtner JJ; McIntosh BA; Holmes-Rovner M
J Rheumatol; 2008 Apr; 35(4):618-24. PubMed ID: 18278840
[TBL] [Abstract][Full Text] [Related]
16. Application of explicit process of care measurement to rheumatoid arthritis: Moving from evidence to practice.
Kahn KL; MacLean CH; Liu H; Rubenstein LZ; Wong AL; Harker JO; Chen WP; Fitzpatrick DM; Bulpitt KJ; Traina SB; Mittman BS; Hahn BH; Paulus HE
Arthritis Rheum; 2006 Dec; 55(6):884-91. PubMed ID: 17139665
[TBL] [Abstract][Full Text] [Related]
17. Effect of anakinra on functional status in patients with active rheumatoid arthritis receiving concomitant therapy with traditional disease modifying antirheumatic drugs: evidence from the OMEGA Trial.
Le Loët X; Nordström D; Rodriguez M; Rubbert A; Sarzi-Puttini P; Wouters JM; Woolley JM; Wright N; Lawrence C; Appleton B
J Rheumatol; 2008 Aug; 35(8):1538-44. PubMed ID: 18634163
[TBL] [Abstract][Full Text] [Related]
18. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
[TBL] [Abstract][Full Text] [Related]
19. Mortality in patients with rheumatoid arthritis treated with low-dose oral glucocorticoids. A population-based cohort study.
Sihvonen S; Korpela M; Mustonen J; Huhtala H; Karstila K; Pasternack A
J Rheumatol; 2006 Sep; 33(9):1740-6. PubMed ID: 16881099
[TBL] [Abstract][Full Text] [Related]
20. Time to disease-modifying antirheumatic drug treatment in rheumatoid arthritis and its predictors: a national, multicenter, retrospective cohort.
Tavares R; Pope JE; Tremblay JL; Thorne C; Bykerk VP; Lazovskis J; Blocka KL; Bell MJ; Lacaille D; Hitchon CA; Fitzgerald AA; Fidler WK; Bookman AA; Henderson JM; Mosher DP; Sholter DE; Khraishi M; Haraoui B; Chen H; Li X; Laupacis A; Boire G; Tomlinson G; Bombardier C
J Rheumatol; 2012 Nov; 39(11):2088-97. PubMed ID: 22896027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
